跳至主要内容
临床试验/CTIS2024-510866-18-00
CTIS2024-510866-18-00进行中(未招募)1 期

Comparative study of the mechanism of action of Dry Needling and Botulinum Toxin type A as a treatment for lower limb post-stroke spasticity: a proof of concept controlled trial - 49317

未提供0 个研究点目标入组 60 人开始时间: 2024年3月29日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • aged 18-85 years old, having lower limb post-stroke spasticity in ankle plantar flexors (MAS scores of 1, 1+ and 2);, having had a first stroke, having no more than 12 months of evolution since stroke; 5) having no previous Dry Needling (DN) or Botulinum Toxin type A (BTX A) treatment for spasticity, having ankle PROM = 20° (approx.) when the knee is supported in ~30° flexion, being able to walk independently with or without aids, having no previous Dry Needling (DN) or Botulinum Toxin type A (BTX A) treatment for spasticity

排除标准

  • medical conditions interfering with data interpretation, any contraindication to receiving BTX A or PS treatment, If taking anti-spasticity medications, participants must be on stable medication for at least 3 months prior to the start of the study and neither the dose nor the medication can be changed during the trial, Pregnancy and/or Breastfeeding

研究者

发起方
未提供

相似试验